Safety Concerns Regarding 5α Reductase Inhibitors for the Treatment of Androgenetic Alopecia
April 2015
in “
Current Opinion in Endocrinology, Diabetes and Obesity
”
Studysummary This review discusses the potential persistent adverse effects associated with 5α reductase inhibitor treatment for androgenetic alopecia but provides no new clinical results; it emphasizes the importance of discussing these risks with patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.lww.com →